Augmedix, Inc. (AUGX)
2.350
0.00 (0.00%)
Inactive · Last trade price on Oct 1, 2024

Company Description

Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States.

Its platform offers Augmedix Live that provides synchronous medical note documentation and point of care support; Augmedix Go Assist that offers asynchronous medical documentation based upon previously recorded visits; Augmedix Prep that provides patient demographics, past medical history, medication changes and other points from the patient’s health record; and Augmedix Go, an autonomous, ambient AI mobile software application that offers fully automated medical documentation based upon recorded visits.

The company enables clinicians to access its applications through mobile devices, such as smartphones.

It serves health systems and specialty groups. The company was formerly known as Malo Holdings Corporation and changed its name to Augmedix, Inc. in October 2020.

The company was founded in 2013 and is headquartered in San Francisco, California.

Augmedix, Inc.
Augmedix logo
Country United States
Founded 2013
Industry Health Information Services
Sector Healthcare
Employees 1,430
CEO Emmanuel Krakaris

Contact Details

Address:
111 Sutter Street, Suite 1300
San Francisco, California 94104
Phone 888 669 4885
Website augmedix.com

Stock Details

Ticker Symbol AUGX
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001769804
CUSIP Number 05105P107
ISIN Number US05105P1075
Employer ID 83-3299164
SIC Code 7389

Key Executives

Name Position
Emmanuel Krakaris President, Chief Executive Officer, Secretary and Director
Ian Shakil Founder, Chief Strategy Officer and Director
Sandra Breber Chief Operating Officer
Paul Louis Ginocchio Chief Financial Officer
Saurav Chatterjee Ph.D. Chief Technology Officer
Todd Holvick Head of Legal and Compliance
Lia Wallick Head of People
Dr. Davin Lundquist M.D. Chief Medical Officer
Jonathan Hawkins Chief Revenue Officer
Tomer Levy Senior Vice President of Engineering

Latest SEC Filings

Date Type Title
Oct 15, 2024 15-12G Securities registration termination
Oct 4, 2024 SC 13D/A [Amend] General statement of acquisition of beneficial ownership
Oct 3, 2024 EFFECT Notice of Effectiveness
Oct 3, 2024 EFFECT Notice of Effectiveness
Oct 3, 2024 EFFECT Notice of Effectiveness
Oct 2, 2024 25-NSE Filing
Oct 2, 2024 S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
Oct 2, 2024 S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
Oct 2, 2024 S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
Oct 2, 2024 S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments